KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Equity: 2016-2025

Historic Return on Equity for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 0.02%.

  • BeOne Medicines' Return on Equity rose 27.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 27.00%. This contributed to the annual value of -0.19% for FY2024, which is 3.00% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Return on Equity is 0.02%, which was up 135.51% from -0.05% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Return on Equity ranged from a high of 0.02% in Q3 2025 and a low of -0.45% during Q1 2023.
  • In the last 3 years, BeOne Medicines' Return on Equity had a median value of -0.23% in 2024 and averaged -0.21%.
  • Per our database at Business Quant, BeOne Medicines' Return on Equity increased by 30bps in 2021 and then fell by 14bps in 2022.
  • Over the past 5 years, BeOne Medicines' Return on Equity (Quarterly) stood at -0.30% in 2021, then decreased by 14bps to -0.44% in 2022, then rose by 20bps to -0.24% in 2023, then climbed by 5bps to -0.19% in 2024, then climbed by 27bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, -0.05% for Q2 2025, and -0.11% during Q1 2025.